The ABC transporters MDR1 and MRP2: multiple functions in disposition of xenobiotics and drug resistance (Q35956193)

11 August 2017

1 reference

title

The ABC transporters MDR1 and MRP2: multiple functions in disposition of xenobiotics and drug resistance (English)

1 reference

11 August 2017

main subject

multiple drug resistance

1 reference

1 reference

Heyo K Kroemer

1 reference

11 August 2017

Ulrich Hoffmann

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

11 August 2017

published in

Drug Metabolism Reviews

1 reference

11 August 2017

1 reference

11 August 2017

issue

3-4

1 reference

11 August 2017

page(s)

669-701

1 reference

Altered expression and function of P-glycoprotein (170 kDa), encoded by the MDR 1 gene, in T cell subsets from aging humans

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Biochemical, cellular, and pharmacological aspects of the multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

P-glycoprotein: from genomics to mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Role of transport proteins in drug absorption, distribution and excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

The role of P-glycoprotein in determining the oral absorption and clearance of the NK2 antagonist, UK-224,671.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

The drug efflux-metabolism alliance: biochemical aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Differential Modulation of the Human Liver Conjugate Transporters MRP2 and MRP3 by Bile Acids and Organic Anions

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Mammalian ABC transporters in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

The multidrug resistance protein family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

A family of drug transporters: the multidrug resistance-associated proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

ABC transporters as phenotypic markers and functional regulators of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Mechanism of inhibition of P-glycoprotein-mediated drug transport by protein kinase C blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Protein kinase C effectors bind to multidrug ABC transporters and inhibit their activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Reversal of multidrug resistance by the P-glycoprotein modulator, LY335979, from the bench to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Secondary structure of P-glycoprotein investigated by circular dichroism and amino acid sequence analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

P-glycoprotein-mediated intestinal and biliary digoxin transport in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Peptide mimetic HIV protease inhibitors are ligands for the orphan receptor SXR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Hepatic transport systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Strategies for reversing drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine [seecomments]

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Anti-P-glycoprotein antibody-induced apoptosis of activated peripheral blood lymphocytes: a possible role of P-glycoprotein in lymphocyte survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

P-glycoprotein and multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

St Johns wort increases expression of P-glycoprotein: implications for drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

ABC Transporters: From Microorganisms to Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

ABC transporters: physiology, structure and mechanism--an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Structural, mechanistic and clinical aspects of MRP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Multidrug resistance-associated proteins: Export pumps for conjugates with glutathione, glucuronate or sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Allosteric interactions between the two non-equivalent nucleotide binding domains of multidrug resistance protein MRP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Hammerhead ribozyme against gamma-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Polymorphisms in the ABCC2 (cMOAT/MRP2) gene found in 72 established cell lines derived from Japanese individuals: an association between single nucleotide polymorphisms in the 5'-untranslated region and exon 28.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Dialkylquinonimines validated as in vivo metabolites of alachlor, acetochlor, and metolachlor herbicides in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Multiple physiological functions for multidrug transporter P-glycoprotein?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

A new structural model for P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Symmetry and structure in P-glycoprotein and ABC transporters what goes around comes around

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

A Mechanism for P-Glycoprotein-Mediated Apoptosis As Revealed by Verapamil Hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg(3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

An inventory of the human ABC proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Novel macrolide-specific ABC-type efflux transporter in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Bacterial multidrug resistance mediated by a homologue of the human multidrug transporter P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

The MRP family of drug efflux pumps

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

MRP subfamily transporters and resistance to anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Enterohepatic bile salt transporters in normal physiology and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Intestinal secretion is a major route for parent ivermectin elimination in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

beta-Amyloid efflux mediated by p-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Do multidrug resistance-associated protein-1 and -2 play any role in the elimination of estradiol-17 beta-glucuronide and 2,4-dinitrophenyl-S-glutathione across the blood-cerebrospinal fluid barrier?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

The Leishmania ATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

ATP binding cassette transporters and drug resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Overexpression of cMOAT (MRP2/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Role of P-glycoprotein in pharmacokinetics: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Multidrug resistance: a role for cholesterol efflux pathways?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Determining the structure and mechanism of the human multidrug resistance P-glycoprotein using cysteine-scanning mutagenesis and thiol-modification techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Induction of proteins involved in multidrug resistance (P-glycoprotein, MRP1, MRP2, LRP) and of CYP 3A4 by rifampicin in LLC-PK1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Vascular and Parenchymal Mechanisms in Multiple Drug Resistance: a Lesson from Human Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Homozygous mutation Arg768Trp in the ABC-transporter encoding gene MRP2/cMOAT/ABCC2 causes Dubin-Johnson syndrome in a Caucasian patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Cytokine regulation of P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Frequency of the mutant MDR1 allele associated with ivermectin sensitivity in a sample population of collies from the northwestern United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Transcriptional control of hepatocanalicular transporter gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Ivermectin excretion by isolated functionally intact brain endothelial capillaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

P-glycoprotein-mediated transport of digitoxin, alpha-methyldigoxin and beta-acetyldigoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

The drug efflux pump MRP2: regulation of expression in physiopathological situations and by endogenous and exogenous compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

P-glycoprotein--a novel therapeutic target for immunomodulation in clinical transplantation and autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

The subpopulation of CF-1 mice deficient in P-glycoprotein contains a murine retroviral insertion in the mdr1a gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

FROM VACUOLAR GS-X PUMPS TO MULTISPECIFIC ABC TRANSPORTERS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

P-glycoprotein inhibits caspase-8 activation but not formation of the death inducing signal complex (disc) following Fas ligation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Molecular aspects of renal anionic drug transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Homozygous disruption of the mdrla P-glycoprotein gene affects blood-nerve barrier function in mice administered with neurotoxic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Genetic polymorphisms of the human MDR1 drug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Energy dependent transport of xenobiotics and its relevance to multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Insights into the structure and substrate interactions of the P-glycoprotein multidrug transporter from spectroscopic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

The involvement of sphingolipids in multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

The expression of P-glycoprotein and multidrug resistance proteins 1 and 2 (MRP1 and MRP2) in human malignant mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Pharmacogenomics of ABC transporters and its role in cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): its impact on drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Transporter-mediated permeation of drugs across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Role of P-glycoprotein in drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

A new mutation of the ATP-binding cassette, sub-family C, member 2 (ABCC2) gene in a Japanese patient with Dubin-Johnson syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

The medicinal chemistry of multidrug resistance (MDR) reversing drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Bile salt transporters: molecular characterization, function, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Altered conjugate formation and altered apoptosis of multidrug‐resistant human leukemia cell line affects susceptibility to killing by activated natural killer (NK) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Exon-intron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

A bacterial antibiotic-resistance gene that complements the human multidrug-resistance P-glycoprotein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Development of multidrug-resistance convertors: sense or nonsense?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Disposition of docetaxel in the presence of P-glycoprotein inhibition by intravenous administration of R101933.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Blockage of multidrug resistance-associated proteins potentiates the inhibitory effects of arsenic trioxide on CYP1A1 induction by polycyclic aromatic hydrocarbons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

A splice mutation in the human canalicular multispecific organic anion transporter gene causes Dubin-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Identification of a novel 2026G-->C mutation of the MRP2 gene in a Japanese patient with Dubin-Johnson syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

The farnesyl protein transferase inhibitor lonafarnib (SCH66336) is an inhibitor of multidrug resistance proteins 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Inhibition of P-glycoprotein by newer antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Induction of the multispecific organic anion transporter (cMoat/mrp2) gene and biliary glutathione secretion by the herbicide 2,4,5-trichlorophenoxyacetic acid in the mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Interaction of cytochrome P450 3A inhibitors with P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

ABC transporters: bacterial exporters-revisited five years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Ceramide glycosylation potentiates cellular multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-200033473

Expression and characterization of DrrA and DrrB proteins of Streptomyces peucetius in Escherichia coli: DrrA is an ATP binding protein

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1128/JB.179.3.569-575.1997

Identifiers

DOI

10.1081/DMR-200033473

1 reference

11 August 2017

1 reference